Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Whitson B. Etheridge"'
Autor:
Syed Shahyan Bakhtiyar, Gabriel Loor, Abbas Rana, John A. Goss, Elizabeth L. Godfrey, Jeffrey A. Morgan, Whitson B. Etheridge, Faisal H. Cheema, Andrew B. Civitello, Harveen K. Lamba, Shayan Ahmed
Publikováno v:
JAMA Cardiol
IMPORTANCE: With continuing improvements in medical devices and more than a decade since the 2006 United Network for Organ Sharing (UNOS) allocation policy, it is pertinent to assess survival among patients on the heart transplantation waiting list,
Autor:
Masashi Kawabori, Andre C. Critsinelis, Reynolds M. Delgado, Ajith Nair, O.H. Frazier, Joggy George, Chitaru Kurihara, Tadahisa Sugiura, Jeffrey A. Morgan, Leo Simpson, Azeen Anjum, Whitson B. Etheridge, Andrew B. Civitello
Publikováno v:
Journal of Artificial Organs. 21:285-292
Continuous-flow left ventricular assist devices (CF-LVADs) are increasingly being used to treat advanced, refractory chronic heart failure. Herein, we sought to determine the incidence of postoperative acute kidney injury (AKI) in axial-flow (HeartMa
Autor:
Sarah A. Shearer, Whitson B. Etheridge
Publikováno v:
Mechanical Circulatory Support for Advanced Heart Failure ISBN: 9783319653631
Heart disease is associated with chronic and acute kidney disease. Decreased glomerular filtration rate negatively affects the prognosis of heart failure. Renal and liver dysfunctions often improve after left ventricular assist device placement, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c35017eea7b89b1a5c2ca6d6c51cacf9
https://doi.org/10.1007/978-3-319-65364-8_9
https://doi.org/10.1007/978-3-319-65364-8_9
Autor:
Rajko Radovancevic, Hari R. Mallidi, Steve K. Singh, Ana Maria Segura, O.H. Frazier, Ruben Hernandez, Whitson B. Etheridge, Zumrut T. Demirozu, William E. Cohn
Publikováno v:
Journal of Cardiac Surgery. 29:419-423
Background We sought to determine the outcomes for patients with advanced hepatic dysfunction undergoing HeartMate II left ventricular assist device (LVAD) implantation. Methods Between November 1, 2003 and December 1, 2012, we implanted the HeartMat
Autor:
Whitson B. Etheridge, Barry D. Kahan
Publikováno v:
Current Opinion in Organ Transplantation. 12:624-635
Publikováno v:
Circulation. Heart failure. 6(3)
A 38-year-old man with a history of ischemic cardiomyopathy was admitted to the hospital for shortness of breath 6 months after receiving a HeartMate II left ventricular assist device (LVAD; Thoratec Corporation, Pleasanton, CA). The patient had volu
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 32(2)
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 30(2)
Background Renal function is often compromised in patients with advanced heart failure. Methods We evaluated renal function in heart failure patients supported by the HeartMate II (Thoratec Corporation, Pleasanton, CA) continuous-flow left ventricula
Publikováno v:
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 16(1)
Humoral rejection (HR) of the cardiac allograft is neither well characterized nor universally recognized in the transplant/pathology-related literature. One reason for this is that the histologic light-microscopic features are inconsistent, making HR
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 24(4)